Stock Price
0.62
Daily Change
-0.04 -6.06%
Monthly
-8.15%
Yearly
604.55%
Q2 Forecast
0.61

Starpharma Holdings reported AUD-873K in EBIT for its fiscal semester ending in December of 2025.





Ebit Change Date
Medical Developments International AUD -36K 12.96M Dec/2025
Mesoblast USD -27.75M 14.36M Dec/2025
Neuren Pharmaceuticals AUD 17.01M 154.09M Dec/2025